RhumbLine Advisers’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
70,638
+722
| +1% | +$4.25K | ﹤0.01% | 2799 |
|
|
2025
Q1 | $587K | Buy |
69,916
+3,843
| +6% | +$32.2K | ﹤0.01% | 2473 |
|
|
2024
Q4 | $492K | Buy |
66,073
+1,300
| +2% | +$9.67K | ﹤0.01% | 2691 |
|
|
2024
Q3 | $376K | Sell |
64,773
-28,076
| -30% | -$163K | ﹤0.01% | 2896 |
|
|
2024
Q2 | $617K | Buy |
92,849
+31,281
| +51% | +$208K | ﹤0.01% | 2522 |
|
|
2024
Q1 | $803K | Buy |
61,568
+1,208
| +2% | +$15.8K | ﹤0.01% | 2376 |
|
|
2023
Q4 | $770K | Sell |
60,360
-479
| -0.8% | -$6.11K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $798K | Buy |
60,839
+2,123
| +4% | +$27.8K | ﹤0.01% | 2337 |
|
|
2023
Q2 | $1.5M | Buy |
58,716
+10,559
| +22% | +$270K | ﹤0.01% | 2068 |
|
|
2023
Q1 | $1.21M | Buy |
48,157
+5,386
| +13% | +$136K | ﹤0.01% | 2040 |
|
|
2022
Q4 | $983K | Buy |
42,771
+1,054
| +3% | +$24.2K | ﹤0.01% | 2138 |
|
|
2022
Q3 | $921K | Buy |
41,717
+3,338
| +9% | +$73.7K | ﹤0.01% | 2172 |
|
|
2022
Q2 | $550K | Buy |
38,379
+9,640
| +34% | +$138K | ﹤0.01% | 2456 |
|
|
2022
Q1 | $543K | Buy |
28,739
+7,673
| +36% | +$145K | ﹤0.01% | 2392 |
|
|
2021
Q4 | $393K | Buy |
21,066
+13,061
| +163% | +$244K | ﹤0.01% | 2606 |
|
|
2021
Q3 | $215K | Buy |
8,005
+525
| +7% | +$14.1K | ﹤0.01% | 2886 |
|
|
2021
Q2 | $234K | Buy |
+7,480
| New | +$234K | ﹤0.01% | 2878 |
|